Tanvex Biopharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. It offers biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis.
|HQ||New Taipei City, TW||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (17-Sept-2021)
Closing stock price (17-Sept-2021)
|TWD||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020||Q1, 2021|
Depreciation and Amortization
Cash From Operating Activities
Purchases of PP&E
|Company Name||Date||Deal Size|
|La Jolla Biologics Inc.||September 30, 2014|
|Tanvex Biologics Corporation||September 30, 2013|
|Tanvex BioPharma USA, Inc.|
When was Tanvex Biopharma founded?
Tanvex Biopharma was founded in 2013.
Who are Tanvex Biopharma key executives?
Tanvex Biopharma's key executives are Chen Lin-Cheng, Allen Chao and David Hsia.
How many employees does Tanvex Biopharma have?
Tanvex Biopharma has 148 employees.
What is Tanvex Biopharma revenue?
Latest Tanvex Biopharma annual revenue is NT$300 k.
What is Tanvex Biopharma revenue per employee?
Latest Tanvex Biopharma revenue per employee is NT$2 k.
Who are Tanvex Biopharma competitors?
Competitors of Tanvex Biopharma include OBI Pharma, PharmaEssentia and Bora Pharmaceuticals.
Where is Tanvex Biopharma headquarters?
Tanvex Biopharma headquarters is located at 33F., No.99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City.
Where are Tanvex Biopharma offices?
Tanvex Biopharma has offices in New Taipei City, Taipei City, Irvine and San Diego.
How many offices does Tanvex Biopharma have?
Tanvex Biopharma has 5 offices.
Receive alerts for 300+ data fields across thousands of companies